Our findings in the previous grant period included that platelet-derived growth factor (PDGF) receptors (PDGFRs) are present in epiretinal membranes of human proliferative vitreoretinopathy (PVR) donors, and that PDGFRs are required for development of PVR in a rabbit model of the disease. We will continue to investigate the role of PDGF in PVR as outlined in these specific aims: 1. To investigate why the alphaPDGFR is better at causing PVR than the betaPDGFR. In the rabbit model of PVR, cells expressing the alphaPDGFR induce PVR much more effectively than do the same cells expressing the betaPDGFR. We will identify the region(s) of the alphaPDGFR that enable the betaPDGFR to induce PVR by using chimeras of the alpha and betaPDGFRs. 2. Test the hypothesis that TGFbeta activates the alphaPDGFR via PDGF-CC. Activation of the PDGFR is a prerequisite for PVR in rabbits, and in this aim we will test whether our recently discovered unconventional, transforming growth factor beta (TGFbeta)-dependent route to activate the alphaPDGFR is dependent on PDGF-CC. 3. Identify factors that augment the PVR potential of retinal pigment epithelial cells (RPEs). While fibroblasts efficiently induce PVR in our rabbit model, RPE cells do not. This deficiency will be exploited to identify factors that elevate the PVR potential of RPE cells. 4. Screen epiretinal membranes from human PVR donors for expression of factors that promote PVR in the animal model. We will screen epiretinal membranes from human PVR donors for the expression of factors that are critical for PVR in the rabbit model (like alphaPDGFR, activated alphaPDGFR and ligands for this receptor). Together these studies will identify factors that promote PVR and elucidate the relationships between such factors. In addition, our finding will critically evaluate the relevance of the rabbit model to human disease. This information will guide future efforts to develop approaches to prevent and/or treat PVR in humans.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY012509-05
Application #
6708573
Study Section
Special Emphasis Panel (ZRG1-VISC (01))
Program Officer
Chin, Hemin R
Project Start
2000-08-01
Project End
2009-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
5
Fiscal Year
2004
Total Cost
$490,000
Indirect Cost
Name
Schepens Eye Research Institute
Department
Type
DUNS #
073826000
City
Boston
State
MA
Country
United States
Zip Code
02114
Huang, Xionggao; Zhou, Guohong; Wu, Wenyi et al. (2017) Genome editing abrogates angiogenesis in vivo. Nat Commun 8:112
Wu, Wenyi; Duan, Yajian; Ma, Gaoen et al. (2017) AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro. Invest Ophthalmol Vis Sci 58:6082-6090
Huang, Xionggao; Zhou, Guohong; Wu, Wenyi et al. (2017) Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation. Invest Ophthalmol Vis Sci 58:1228-1236
Zhou, Guohong; Duan, Yajiang; Ma, Gaoen et al. (2017) Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci 58:5361-5367
Wu, Wenyi; Tang, Luosheng; D'Amore, Patricia A et al. (2017) Application of CRISPR-Cas9 in eye disease. Exp Eye Res 161:116-123
Duan, Yajian; Ma, Gaoen; Huang, Xionggao et al. (2016) The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells. J Biol Chem 291:16339-47
Ma, Gaoen; Duan, Yajian; Huang, Xionggao et al. (2016) Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases. Invest Ophthalmol Vis Sci 57:3935-43
Pennock, Steven; Kim, Leo A; Kazlauskas, Andrius (2016) Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor ? To Promote Viability of Cells Enduring Hypoxia. Mol Cell Biol 36:2314-27
Lei, Hetian; Qian, Cynthia X; Lei, Jinghu et al. (2015) RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology. Mol Cell Biol 35:1673-85
Pennock, Steven; Haddock, Luis J; Eliott, Dean et al. (2014) Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy? Prog Retin Eye Res 40:16-34

Showing the most recent 10 out of 33 publications